Author:
de Vries Hilbert S.,de Heij Tineke,Roelofs Henie M. J.,te Morsche Rene H. M.,Peters Wilbert H. M.,de Jong Dirk J.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference27 articles.
1. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354:731–739.
2. Rogler G. Gastrointestinal and liver adverse effects of drugs used for treating IBD. Best Pract Res Clin Gastroenterol. 2010;24:157–165.
3. Khokhar OS, Lewis JH. Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis. 2010;28:508–518.
4. US Food and Drug Association (2004) MedWatch safety alerts for human medical products. http://www.fda.gov/medWatch/safety/2004/remicade_DHCP_dec04.pdf . Accessed 5 April 2012
5. Federal Drug Administration (2009) REMICADE® (infliximab) for IV Injection. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103772s5234lbl.pdf . Accessed 5 April 2012
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献